This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SuperGen's CEO Discusses Q2 2011 Results - Earnings Call Transcript

SuperGen (SUPG)

Q2 2011 Earnings Call

August 03, 2011 9:00 am ET

Executives

Mohammad Azab - Chief Medical Officer

James Manuso - Chairman of the Board, Chief Executive Officer and President

Michael Molkentin - Chief Financial Officer, Principal Accounting Officer and Corporate Secretary

Timothy Enns - Senior Vice President of Corporate Communications & Business Development

Harren Jhoti - Co-Founder, Chief Executive Officer, Clinical Consultant, Director and Member of Scientific Advisory Board

Analysts

Elemer Piros - Rodman & Renshaw, LLC

John Nelson - State of Wisconsin Investment Board

George Zavoico - McNicoll, Lewis & Vlak LLC

Robin Davison - Edison Investment Research Limited

Presentation

Operator

Good morning, my name is Brooke, and I'll be your conference operator today. At this time, I would like to welcome everyone to the SuperGen Second Quarter 2011 Earnings Conference Call. [Operator Instructions] I will now turn the conference over to Mr. Timothy Enns, Senior VP of Corporate Communications and Marketing. Thank you. Mr. Enns, you may begin your conference.

Timothy Enns

Thank you, Brooke. Good day, and thank you for joining us for SuperGen's 2011 Second Quarter Financial Results Conference Call. With me today are Dr. James Manuso, Chairman and Chief Executive Officer; Dr. Harren Jhoti, President and member of the Board of Directors; Dr. Mohammad Azab, Chief Medical Officer; Dr. Martin Buckland, Chief Business Officer; and Michael Molkentin, Chief Financial Officer. In a few moments, Jim Manuso, Harren Jhoti and Michael Molkentin will deliver remarks on the 2011 second quarter financial results and will provide a summary of our business outlook. After our prepared comments, we will open the line for questions.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs